An integrated analysis of hyponatremia in cancer patients receiving platinum-based or nonplatinum-based chemotherapy in clinical trials (JCOG1405-A)

BACKGROUND: Hyponatremia is a common electrolyte abnormality in cancer patients who receive chemotherapy. Among anticancer agents, platinum-based agents are reported to cause chemotherapy-induced hyponatremia. However, the actual incidence and risk factors remain unknown. RESULTS: The reports of 29...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezoe, Yasumasa, Mizusawa, Junki, Katayama, Hiroshi, Kataoka, Kozo, Muto, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814235/
https://www.ncbi.nlm.nih.gov/pubmed/29464095
http://dx.doi.org/10.18632/oncotarget.23536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814235/
https://www.ncbi.nlm.nih.gov/pubmed/29464095
http://dx.doi.org/10.18632/oncotarget.23536

Ejemplares similares